MedTrace Logo

Adjuvant Radiation Therapy in Treating Patients With Brain Metastases

NCT00002899 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 340

Last updated 2012-07-02

No results posted yet for this study

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Adjuvant radiation therapy may kill any remaining tumor cells following surgery or radiosurgery for brain metastases.

PURPOSE: This randomized phase III trial is studying surgery or radiosurgery alone to see how well it works compared to surgery or radiosurgery and whole-brain radiation therapy in treating brain metastases in patients with solid tumors.

Conditions

Interventions

PROCEDURE

adjuvant therapy

RADIATION

radiation therapy

RADIATION

stereotactic radiosurgery

Sponsors & Collaborators

  • European Organisation for Research and Treatment of Cancer - EORTC

    lead NETWORK

Principal Investigators

  • Rolf-Peter Mueller, MD · Medizinische Universitaetsklinik I at the University of Cologne

  • Riccardo Soffietti, MD · Universita Degli Studi di Turin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-11-30
Primary Completion
2007-11-30

Countries

  • Belgium
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Latvia
  • Netherlands
  • Portugal
  • Spain
  • Switzerland
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002899 on ClinicalTrials.gov